| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| 03/31/2022 |
Director
Trans History: 97
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 507 | -- | 41,308 |
| 03/22/2022 |
Director, Chief Executive Officer
Trans History: 327
|
Director, Chief Executive Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60 | $43.71 | 2,686 |
| 12/31/2021 |
Director
Trans History: 49
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 475 | -- | 15,967 |
| 12/10/2021 |
Senior Vice President
Trans History: 119
|
Senior Vice President | Form 4 | Other acquisition or disposition | -- | -- | 2,828 |
| 12/9/2021 |
Senior Vice President
Trans History: 119
|
Senior Vice President | Form 4 | Open market or private sale of non-derivative or derivative security | 3,155 | $40.34 | 22,405 |
| 10/1/2021 |
Director
Trans History: 207
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 11 | $42.13 | 49,520 |
| 09/30/2021 |
Director
Trans History: 131
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 448 | -- | 111,931 |
| 09/30/2021 |
Director
Trans History: 127
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 616 | -- | 52,181 |
| 09/30/2021 |
Director
Trans History: 207
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 466 | -- | 49,508 |
| 09/1/2021 |
Director
Trans History: 207
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 12 | $41.17 | 48,728 |
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.